Godavari Drugs
add_icon

Godavari Drugs

87.80
+2.78
(3.27%)
Market Cap
66.09 Cr
PE Ratio
14.61
Volume
791.00
Day High - Low
88.84 - 85.60
52W High-Low
115.00 - 69.70
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
66.09 Cr
EPS
5.82
PE Ratio
14.61
PB Ratio
1.48
Book Value
57.56
EBITDA
12.80
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
10.10
Debt to Equity
1.48
Forecast For
Actual

Company News

View All News
Caret
positive
Godavari Drugs Limited board approves preferential issue of 23.60 lakh convertible warrants and 25.97 lakh equity shares at ₹89 each to promoters and non-promoters, subject to shareholder approval in EGM scheduled for February 12, 2026.
neutral
Godavari Drugs Limited responds to BSE inquiry on share price volatility, stating no unpublished price sensitive information exists and attributing movement to market-driven demand-supply factors.
neutral
Godavari Drugs Reports Mixed Q2 Performance with Revenue Growth but Margin PressureNov 14, 2025
Godavari Drugs Limited reported revenue from operations of Rs 2,664.04 lakhs for the quarter ended September 30, 2025, up from Rs 2,608.79 lakhs in the same quarter last year, with net profit rising to Rs 100.07 lakhs from Rs 108.86 lakhs. The company's half-year revenue reached Rs 5,046.07 lakhs compared to Rs 5,829.54 lakhs in the previous year, while net profit for the six-month period stood at Rs 204.13 lakhs versus Rs 271.94 lakhs last year.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,627.90
#1 3,90,587.74
35.27
#1 54,729.00
9.71
#1 10,980
16.07
39.38
5,952.50
1,58,020.17
64.55
9,712.00
18.67
2,191
35.10
34.69
3,987.20
1,34,944.97
63.17
11,539.40
6.99
1,911
30.46
54.84
1,311.60
1,05,947.35
23.63
28,409.50
7.12
5,291
-57.18
23.03
1,182.50
98,695.04
17.87
33,741.20
16.73
5,725
-15.28
40.19
2,129.40
97,270.74
22.48
22,909.50
13.74
3,306
#1 72.75
48.01
879.65
88,513.37
#1 17.58
23,511.00
18.55
4,615
34.60
40.59
2,063.80
85,194.71
48.71
12,744.20
#1 20.90
2,007
-21.05
38.50
1,171.00
68,011.87
19.85
32,345.60
9.43
3,484
3.81
49.49
5,521.50
66,017.81
27.58
13,458.30
3.70
2,216
10.98
36.71
Growth Rate
Revenue Growth
-27.34 %
Net Income Growth
-20.00 %
Cash Flow Change
-39.16 %
ROE
-29.07 %
ROCE
-34.05 %
EBITDA Margin (Avg.)
26.55 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
55
71
76
65
84
96
123
161
160
157
114
106
Expenses
49
67
70
60
78
90
113
150
150
143
102
95
EBITDA
6
5
6
5
6
6
10
12
11
14
13
11
Operating Profit %
11 %
6 %
7 %
6 %
7 %
6 %
8 %
7 %
6 %
8 %
10 %
10 %
Depreciation
1
1
1
1
1
1
1
2
2
2
2
3
Interest
1
2
3
2
3
3
3
3
4
5
5
4
Profit Before Tax
5
2
3
1
2
2
6
7
5
7
6
5
Tax
1
1
1
1
1
0
2
2
1
1
1
1
Net Profit
4
1
2
1
1
2
4
5
4
6
4
4
EPS in ₹
4.84
1.79
2.40
1.10
1.60
2.66
5.48
6.97
5.03
7.37
5.82
4.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
35
51
56
63
74
84
91
101
121
135
143
Fixed Assets
7
9
13
15
15
14
22
26
25
27
33
Current Assets
27
40
43
47
57
61
68
74
87
89
79
Capital Work in Progress
0
1
0
1
2
9
1
1
9
18
30
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
27
41
43
48
57
61
68
75
87
90
81
Total Liabilities
35
51
56
63
74
84
91
101
121
135
143
Current Liabilities
17
31
34
37
46
51
51
58
74
82
73
Non Current Liabilities
5
5
6
9
9
12
16
14
14
14
27
Total Equity
13
14
16
17
18
20
24
30
33
39
43
Reserve & Surplus
6
7
9
10
11
13
17
22
26
31
36
Share Capital
8
8
8
8
8
8
8
8
8
8
8

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
1
-0
-0
0
1
1
-1
-0
Investing Activities
-0
-2
-3
-3
-2
-7
-1
-5
-9
-13
-20
Operating Activities
-6
-5
5
4
4
6
1
11
13
18
11
Financing Activities
6
7
-2
-0
-2
0
0
-6
-4
-6
8

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
55.86 %
56.13 %
56.13 %
56.13 %
56.36 %
56.92 %
56.92 %
53.12 %
53.12 %
53.16 %
53.16 %
53.16 %
53.16 %
53.16 %
52.63 %
52.63 %
52.63 %
52.63 %
52.61 %
52.61 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
36.16 %
36.05 %
36.33 %
36.14 %
35.59 %
35.87 %
35.90 %
39.27 %
7.27 %
38.75 %
38.99 %
38.87 %
39.10 %
38.96 %
39.76 %
39.98 %
39.93 %
37.09 %
37.05 %
36.88 %
Others
7.49 %
7.32 %
7.05 %
7.23 %
7.56 %
6.71 %
6.68 %
7.12 %
39.11 %
7.59 %
7.35 %
7.47 %
7.24 %
7.38 %
7.11 %
6.89 %
6.95 %
9.78 %
9.84 %
10.01 %
No of Share Holders
0
4,136
4,567
5,394
5,750
6,034
6,232
5,968
6,555
6,561
7,019
6,894
7,005
7,044
7,709
7,915
7,881
7,828
7,720
7,483

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Feb 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Feb 2026 85.81 85.02
29 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2024 91.80 139.65
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 122.50 117.20
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 102.90 101.35
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 98.48 97.99
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 82.85 86.51
27 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2025 82.57 86.51
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 83.61 84.00

Announcements

CORRIGENDUM IN CONTINUATION TO THE NOTICE AND EXPLANATORY STATEMENT ATTACHED THERETO DATED 15.01.2026 CONVENING THE 01St EXTRA ORDINARY GENERAL MEETING FOR FY 2025-26 OF GODAVARI DRUGS LIMITED TO BE HELD ON THURSDAY 12.02.2026 AT 11:00 A.M.6 hrs ago
EXTRA-ORDINARY GENERAL MEETING WILL BE HELD ON THURSDAY THE 12TH DAY OF FEBRUARY 2026 AT 11:00 A.M. THROUGH VIDEO CONFERENCING AND OTHER AUDIO-VISUAL MEANSJan 21, 2026
Announcement under Regulation 30 (LODR)-Preferential IssueJan 15, 2026
Board Meeting Outcome for Meeting Held On 15.01.2026Jan 15, 2026
Board Meeting Intimation for Options Of Consideration Of Fund-Raising ProposalJan 12, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2026
Clarification On Price Movement In The Equity Shares Of Godavari Drugs Limited Ref: L/SURV/ONL/PV/AJ/ 2025-2026 / 3277Jan 08, 2026
Clarification sought from Godavari Drugs LtdJan 08, 2026
Closure of Trading WindowDec 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 17, 2025
Unaudited Financials Results Pursuant To Regulation 33 Of The SEBI(LODR) Regulations 2015 For The Quarter And Half Year Ended 30Th September 2025Nov 14, 2025
Board Meeting Outcome for Unaudited Financial Statement For The Half-Year Ended 30Th September 2025Nov 14, 2025
Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On Friday November 14 2025.Nov 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Scrutinizers ReportSep 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 29, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2025
Closure of Trading WindowSep 19, 2025
Dispatch Of Letter To ShareholdersSep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Notice Of 37Th Annual General Meeting Of The CompanySep 03, 2025
Reg. 34 (1) Annual Report.Sep 03, 2025
Intimation Of Book Closure For The Purpose Of 37Th Annual General MeetingSep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Shareholder Meeting / Postal Ballot - 37Th Annual General Meeting Scheduled On 27Th September 2025Aug 13, 2025
Un-Audited Financial Results For The Period Ended 30.06.2025Aug 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2025Aug 13, 2025
Rescheduling Of 37Th Annual General Meeting (AGM) Of The CompanyAug 01, 2025
Board Meeting Intimation for Unaudited Standalone Financial Results Of The Company For The First Quarter Ended 30Th June 2025 And Rescheduling Of 37Th Annual General Meeting (AGM) Of The CompanyAug 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Closure of Trading WindowJun 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
INTIMATION FOR RE-CONSTITUTION OF COMMITTEES OF THE BOARDMay 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2025
AUDITED STANDALONE FINANCIALS OF THE COMPANY FOR THE QUARTER AND YEAR ENDED ON 31-03-2025May 29, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited Held On Thursday 29Th May 2025 Ref: Reg. 30 Read With Reg. 33 Of SEBI (LODR) Regulations 2015 May 29, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Board Meeting Intimation for Approval Of The Audited Financial Results Of The Company Along With Audit Report For The Quarter And Year Ended On 31.03.2025 And Induction Of New Director On The Board Of The CompanyMay 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Integrated Filing (Financial)Feb 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited (The Company) Held On Wednesday 12Th February 2025Feb 12, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 12, 2025
Board Meeting Intimation for Intimation Of The Board Meeting Of Godavari Drugs Limited (The Company) To Be Held On Wednesday February 12 2025.Feb 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 20, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 02, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 31, 2024

Technical Indicators

RSI(14)
Neutral
48.19
ATR(14)
Volatile
7.05
STOCH(9,6)
Neutral
22.76
STOCH RSI(14)
Oversold
1.86
MACD(12,26)
Bearish
-0.93
ADX(14)
Strong Trend
27.29
UO(9)
Bearish
42.06
ROC(12)
Downtrend And Accelerating
-4.33
WillR(14)
Oversold
-95.23